Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
Sweden · Delayed Price · Currency is SEK 2.120
-0.070 (-3.20%)
Oct 15, 2026, 3:26 PM CET
STO:NEWBRY Market Cap
STO:NEWBRY has a market cap or net worth of 64.44 million as of October 15, 2026. It is the 43,711th most valuable company in the world and the 652nd biggest in Sweden. Its market cap has decreased by 11.67% in one year.
Market Cap
64.44M
Enterprise Value
49.76M
Revenue
35.02M
Global Rank
Country Rank
#652 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since February 4, 2022, STO:NEWBRY's market cap has decreased from 245.97M to 64.44M, a decrease of -73.80%. That is a compound annual growth rate of -24.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 64.44M | 84.35% |
| Dec 30, 2025 | 34.96M | -59.06% |
| Dec 30, 2024 | 85.39M | 42.48% |
| Dec 29, 2023 | 59.93M | -56.08% |
| Dec 30, 2022 | 136.45M | -44.52% |
| Feb 4, 2022 | 245.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cereno Scientific AB | 1.13B |
| Dicot Pharma AB | 856.07M |
| EQL Pharma AB | 659.99M |
| Cinclus Pharma Holding AB | 590.10M |
| Moberg Pharma AB | 535.03M |
| Enzymatica AB | 427.21M |
| Orexo AB | 223.92M |
| Klaria Pharma Holding AB (publ.) | 121.14M |